Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €76.50 Price Target at Goldman Sachs Group

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been assigned a €76.50 ($88.95) price objective by equities researchers at Goldman Sachs Group in a report issued on Wednesday, October 23rd, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock. Goldman Sachs Group’s target price would suggest a potential upside of 12.33% from the stock’s current price.

A number of other research analysts have also commented on FME. Berenberg Bank set a €89.95 ($104.59) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Jefferies Financial Group set a €69.00 ($80.23) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Wednesday, September 18th. Deutsche Bank set a €100.00 ($116.28) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Wednesday, July 31st. Nord/LB set a €82.00 ($95.35) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Thursday, August 1st. Finally, UBS Group set a €90.00 ($104.65) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Eight analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of €78.48 ($91.26).

Shares of FME stock traded down €0.92 ($1.07) during trading hours on Wednesday, reaching €68.10 ($79.19). 998,191 shares of the company’s stock were exchanged, compared to its average volume of 704,197. The business has a fifty day moving average price of €61.75 and a 200-day moving average price of €65.60. The company has a quick ratio of 0.62, a current ratio of 0.98 and a debt-to-equity ratio of 101.27. The stock has a market capitalization of $20.76 billion and a P/E ratio of 16.20. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €55.44 ($64.47) and a fifty-two week high of €76.68 ($89.16).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Article: Cost of Goods Sold (COGS)

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News